Lantus SoloStar (Stylo prérempli)
Lantus SoloStar (Stylo prérempli) is a medicine authorised by Swissmedic under authorisation number 58044. The authorisation holder is Sanofi-Aventis (Suisse) SA. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 06 July 2007 and the authorisation is valid without a time limit. ATC code A10AE04 places the medicine in the group Drugs used in diabetes.
| Authorisation number | 58044 |
|---|---|
| Name | Lantus SoloStar (Stylo prérempli) |
| Full name | Lantus SoloStar (Stylo prérempli), solution injectable |
| Authorisation holder | Sanofi-Aventis (Suisse) SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | B · Prescription only |
| ATC code | A10AE04 |
| First authorisation | 06 July 2007 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Lantus SoloStar (Stylo prérempli), solution injectable | B | 06 July 2007 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 5 x 3 | ml | A10AE04 | 07.06.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Lantus SoloStar (Stylo prérempli) authorised in Switzerland?
Yes. Lantus SoloStar (Stylo prérempli) is authorised by Swissmedic under authorisation number 58044, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Lantus SoloStar (Stylo prérempli) have?
Lantus SoloStar (Stylo prérempli) is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Lantus SoloStar (Stylo prérempli)?
The authorisation holder is Sanofi-Aventis (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.